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Abstract
B. parapertussis is a whooping cough etiological agent with the ability to evade the immune
response induced by pertussis vaccines. We previously demonstrated that in the absence
of opsonic antibodies B. parapertussis hampers phagocytosis by neutrophils and macro-
phages and, when phagocytosed, blocks intracellular killing by interfering with phagolysoso-
mal fusion. But neutrophils can kill and/or immobilize extracellular bacteria through non-
phagocytic mechanisms such as degranulation and neutrophil extracellular traps (NETs). In
this study we demonstrated that B. parapertussis also has the ability to circumvent these
two neutrophil extracellular bactericidal activities. The lack of neutrophil degranulation was
found dependent on the O antigen that targets the bacteria to cell lipid rafts, eventually
avoiding the fusion of nascent phagosomes with specific and azurophilic granules. IgG
opsonization overcame this inhibition of neutrophil degranulation. We further observed that
B. parapertussis did not induce NETs release in resting neutrophils and inhibited NETs for-
mation in response to phorbol myristate acetate (PMA) stimulation by a mechanism depen-
dent on adenylate cyclase toxin (CyaA)-mediated inhibition of reactive oxygen species
(ROS) generation. Thus, B. parapertussis modulates neutrophil bactericidal activity through
two different mechanisms, one related to the lack of proper NETs-inducer stimuli and the
other one related to an active inhibitory mechanism. Together with previous results these
data suggest that B. parapertussis has the ability to subvert the main neutrophil bactericidal
functions, inhibiting efficient clearance in non-immune hosts.
Introduction
Bordetella pertussis and Bordetella parapertussis are human pathogens that cause whooping
cough. Epidemiological studies revealed that B. parapertussis infections are globally more
common than expected, affecting mainly vaccinated populations [1]. The incidence in vacci-
nated populations increased after introduction of acellular pertussis vaccines [2]. Current
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acellular pertussis vaccines, formulated with B. pertussis components, fail to protect against
B. parapertussis infections [3–5]. Although cross-immunity could be expected between bac-
teria that share the majority of the vaccine antigens, the O antigen molecule on B. parapertus-
sis surface blocks antibody access to the vaccine antigens common to both species [5]. Thus
B. parapertussis largely avoids opsonophagocytosis and other activities mediated by vaccine-
induced antibodies [5–7], surviving and growing primarily extracellularly within the respira-
tory tract. Avoiding antibody-mediated effects does not prevent exposure to the many other
anti-microbial activities unleashed upon invading bacteria. Neutrophils are rapidly recruited
to the site of bacterial infection. These cells are equipped with extracellular bactericidal
mechanisms, such as degranulation and NETs [8, 9]. Degranulation occurs when specific
membrane receptors are activated and neutrophil cytoplasmic granules translocate to the
plasma membrane [10], or when during bacterial phagocytosis, nascent unclosed phago-
somes fuse with granules releasing their content into the extracellular medium [11, 12]. On
the other hand, NETs have been observed in vivo during infection with bacteria [9, 13, 14],
fungi [15, 16], protozoa [17, 18], and viruses [19–21]. The microbicidal activity of NETs is
mediated by the same components released via degranulation, including neutrophil elastase
(NE), myeloperoxidase, cathepsin G, proteinase 3, bacterial permeability-increasing protein,
lactoferrin, gelatinase, the cathelicidin LL-37, and tryptase with the addition of nuclear anti-
microbial factors as DNA and histones [22, 23]. Therefore, the key difference between NETs
release and degranulation is that the NETs, through their network structure, act as a physical
container of microbes that reduces their dissemination, allowing the microbicidal factors to
exert their action more efficiently, and limiting the damage to the surrounding tissues by
confining antimicrobial agents to a restricted area [9, 24]. NETs released may be induced by
several stimuli including bacterial components, proinflammatory cytokines or PMA [9, 23].
Most of the NETs inducer stimuli initiate NETs release through ROS generated by the activa-
tion of the NADPH oxidase (NOX) system. ROS lead to the translocation of NE from azhur-
ophilic granules to the nucleus where it initiates several chromatin structure rearrangements
leading to chromatin decondensation. Next, the nuclear envelope is dismantled and chroma-
tin is mixed with bactericidal compounds of cytoplasmic, granular, and nuclear origin.
Finally, the cell membrane is broken and NETs are released into the extracellular medium
trapping and/or killing bacteria [25, 26]. Importantly, NETs were found released in the respi-
ratory tract in response to several pathogen infections [16, 19, 27–29], although their role in
whooping cough is still uncertain.
In the present study, we investigated neutrophils extracellular antimicrobial functions
against B. parapertussis and explored how this pathogen is able to resist these functions. Our
results indicate that B. parapertussis is able to evade neutrophil extracellular killing mecha-
nisms if specific antibodies are not present at the site of interaction.
Materials and Methods
Bacterial strains and growth
The B. parapertussis strain CN2591 and the isogenic B. parapertussis mutant strain lacking
the O antigen, CN2591Δwbm [30, 31], were used in this study. Bacteria were stored at -70˚C
and recovered by growth on Bordet-Gengou agar (BGA) (BD Difco) plates supplemented
with 15% defibrinated sheep blood (Laboratorio Argentino, Caseros, Argentina) (bBGA) for
24 h at 36˚C. Animal handling and all procedures were in compliance with the Argentinean
animal protection Law 14346. Virulent (Bvg+) bacteria were subsequently seeded on Stainer-
Scholte (SS) liquid medium, cultured for 20 h at 36˚C, and used in the experiments. Aviru-
lent (Bvg-) B. parapertussis was obtained by growing the bacteria on bBGA plates
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supplemented with magnesium sulfate at a final concentration of 50 mM for 24 h at 36˚C,
subsequently seeded on SS liquid medium containing 50 mM magnesium sulfate, cultured
for 20 h at 36˚C, and used in the experiments. Transition from Bvg+ to Bvg- phase was con-
firmed by the loss of expression of the CyaA and the filamentous hemagglutinin by western
blot analysis of whole-cell lysates as previously described [32] (data not shown). Inactivation
of B. parapertussis was obtained by treating bacterial cells with 4% (w/v) paraformaldehyde
for 1 h, washed once with phosphate-buffered saline (PBS), incubated for 10 min at room
temperature with PBS containing 50 mM NH4Cl, washed, and suspended in the appropriate
medium. Pseudomona aeruginosa strain PA01 was grown for 12 h at 37˚C in Luria–Bertani
medium (Gibco, Rockville, MD).
Cells
Human neutrophils were isolated from heparinized venous blood using Ficoll-Histopaque
(Sigma, St Louis, MO) gradient centrifugation. Neutrophils were harvested and the remaining
erythrocytes were removed by hypotonic lysis. Cell viability was 99% as determined by Trypan
blue exclusion. Prior to functional assays, neutrophils were washed twice with Dulbecco’s
modified Eagle medium (DMEM) (Gibco) supplemented with 10% heat-inactivated fetal calf
serum (FCS) (Gibco), suspended, and used immediately (the presence of heat-stable nucleases
in FCS was discarded as in [33]). All experiments were carried out with freshly isolated neutro-
phils lacking FcγRI expression, as monitored by FACS analysis using a fluorescence-activated
cell sorter FACScalibur flow cytometer with anti-hFcγRI mAb 22 (mIgG1) [34]. Data were
processed using the CellQuest software (BD Biosciences, San Jose, CA). All procedures involv-
ing human samples were in accordance with the ethical standards of the 1964 Helsinki declara-
tion and its later amendments, and approved by the Institutional Review Board. Peripheral
blood was collected from healthy donors. All individuals provided written informed consent
for the collection of samples and subsequent analysis.
Antibodies
The following antibodies were used: mouse anti-human LAMP-1 monoclonal antibodies
(Pharmingen, San Diego, CA), rabbit anti-human flotillin-1 (Santa Cruz Biotechnology, Santa
Cruz, CA), rabbit anti-human NE polyclonal antibodies (Calbiochem-Merk Millipore; Darm-
stad, Germany), mouse anti-hFcγRI (CD64) MAb 22 (mIgG1) (Medarex, Annandale, NJ).
Cy3-conjugated goat F(ab´)2 fragments of anti-rabbit IgG and fluorescein isothiocyanate
(FITC)-conjugated goat F(ab´)2 fragments of anti-rabbit IgG (both from Jackson ImmunoRe-
search, West Grove, PA), Cy3-conjugated goat F(ab´)2 fragments of anti-mouse IgG, phycoer-
ythrin (PE)-conjugated goat F(ab´)2 fragments of anti-mouse IgG (both from Molecular
Probes, Eugene, OR), and FITC-conjugated goat F(ab´)2 fragments of anti-mouse IgG (from
Southern Biotechnology, Birmingham, AL). Immunoglobulin G (IgG) fractions from pooled
sera of whooping cough patients with high titers of anti-B. parapertussis antibodies, as mea-
sured by enzyme-linked immunosorbent assay [35], were isolated as described previously [36].
Polyclonal rabbit anti-B. parapertussis antiserum and polyclonal mouse anti-B. parapertussis
antiserum were obtained as described elsewhere [37].
Respiratory burst determination
ROS production by neutrophils was determined as previously described [7], with minor modi-
fications. Briefly, tubes containing 2x107 bacteria were transferred to a Luminometer (Lumi-
noskan TL Plus, Thermo LabSystems, Finland), in which chemoluminescence response of
2x105 neutrophils was measure every minute for 120 min at 37˚C after injection of 120 μM
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luminol (Sigma). Neutrophils incubated with PMA were used as positive control. Neutrophils
incubated with diphenyleneiodonium (DPI), a NOX inhibitor, 30 min before PMA treatment
were used as a control of inhibition of PMA-induced ROS.
Neutrophil degranulation studies
Exocytosis of the lysosomal enzyme β-glucuronidase was determined as previously described
[38], with minor modifications. Briefly, 2x105 neutrophils were incubated with bacteria at a
multiplicity of infection (MOI) of 300 for 10 min at 37˚C and centrifuged at 300 x g. Super-
natants were further centrifuged at 10,000 x g for 10 min to eliminate bacteria. β-glucuroni-
dase activity was measured at 405 nm in cell lysed with 0.2% (v/v) Triton X-100 (Sigma), and
in the cell-free supernatants. Controls were performed by determination of β-glucuronidase
activity from non-infected 2x105 neutrophils lysed by Triton X-100 treatment, assumed as a
100% of release. Cell-free supernatant of uninfected neutrophils was used as a negative
control.
Confocal microscopy studies were performed as previously described [7], with minor
modifications. Briefly, neutrophils were incubated with B. parapertussis at a MOI of 300 at
37˚C. Ten minutes post infection neutrophils were incubated with or without 200 nM Lyso-
Tracker DND-99 (Molecular Probes) (5 min at 37˚C) prior to fixation with 4% (w/v) para-
formaldehyde. Samples incubated with LysoTracker stain were then washed twice with PBS
and further incubated 10 min at room temperature with PBS containing 50 mM NH4Cl.
After two washing steps, the cells were incubated for 30 min at 25˚C with PBS containing
0.1% (w/v) saponin (Sigma) and 0.2% (w/v) bovine serum albumin (BSA) (Sigma), followed
by incubation with polyclonal rabbit anti-B. parapertussis antiserum (30 min at 25˚C) in the
presence of 0.1% (w/v) saponin and 0.2% (w/v) BSA. After three washing steps, neutrophils
were incubated with FITC-conjugated goat F(ab´)2 fragments of anti-rabbit immunoglobu-
lin (30 min at 25˚C). Samples of infected cells that were not incubated with LysoTracker
stain were washed twice with PBS and incubated for 10 min at room temperature with PBS
containing 50 mM NH4Cl. After two washing steps, the cells were further incubated for 30
min at 25˚C with PBS containing 0.1% (w/v) saponin and 0.2% (w/v) BSA. Next, the cells
were incubated for 30 min at 25˚C with either mouse anti-human LAMP-1 monoclonal anti-
bodies plus polyclonal rabbit anti-B. parapertussis antiserum or rabbit anti-human flotillin-1
plus polyclonal mouse anti-B. parapertussis antiserum antibodies (30 min at 25˚C) in the
presence of 0.1% (w/v) saponin and 0.2% (w/v) BSA. After three washing steps, the cells were
incubated with either Cy3-conjugated F(ab´)2 fragments of goat anti-mouse antibodies plus
FITC-conjugated goat F(ab´)2 fragments of anti-rabbit immunoglobulin or Cy3-conjugated
F(ab´)2 fragments of goat anti-rabbit antibodies plus FITC-conjugated goat F(ab´)2 frag-
ments of anti-mouse immunoglobulin for another 30 min at 25˚C. To avoid cytophilic bind-
ing of antibodies to the FcR, all incubations were done in the presence of 25% (v/v) heat-
inactivated human serum. Additionally, isotype controls were run in parallel. Microscopic
analyses were performed using a confocal laser scanning microscope (model TCS SP5; Leica,
Mannheim, Germany). The percentage of phagosomes containing the bacterium that coloca-
lized with a given marker was calculated from the number of total intracellular bacteria by
analyzing at least 50 phagosomes per donor.
In control studies neutrophils were incubated with 10 mg/ml of β-methyl cyclodextrin
(Sigma) (15 min at 37˚C) in serum-free DMEM plus bovine serum albumin (BSA) (0.2%) and
lovastatin (5 μg/ml) (Sigma) (DMEM-BSA-L), as previously described [7]. Cells were then
washed, suspended in DMEM-BSA-L, and used immediately in infection studies. No decrease
in neutrophils viability was detected after treatment.
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NETs formation studies
NETs formation studies were performed as previously described [9], with minor modifica-
tions. Briefly, 2x105 neutrophils were seeded in 24 well-plates containing 12 mm coverslip and
incubated with bacteria at different MOI (10, 50 or 100), centrifuged for 5 min at 300 × g, and
further incubated at 37˚C for different time periods. Neutrophils incubated with or without
PMA (Sigma) (20 nM) were used as positive and negative control, respectively. In some experi-
ments, neutrophils were incubated with either bacteria or conditioned medium (CM)
(obtained as described below) for 30 min at 37˚C before incubation with PMA (20 nM). Neu-
trophils incubated with DPI 30 min before PMA treatment were used as a control of inhibition
of PMA-induced NETs release. The NETs were visualized by immunofluorescence microscopy
as described below.
Fluorescence microscopy was used to visualize NETting cells. Immunostaining of cells was
performed as described before [7], with minor modifications. At different time points samples
were fixed with 4% (w/v) paraformaldehyde, washed twice with PBS, and incubated for 10 min
at room temperature with PBS containing 50 mM NH4Cl. After two washing steps, the cells
were incubated for 30 min at 25˚C with PBS containing 0.1% (w/v) saponin and 0.2% (w/v)
BSA. Next, the cells were incubated with rabbit anti-human NE polyclonal antibodies (30 min
at 25˚C) in the presence of 0.1% (w/v) saponin and 0.2% (w/v) BSA. After two washing steps,
neutrophils were incubated with FITC-conjugated goat F(ab´)2 fragments of anti-rabbit
immunoglobulin in the presence of 0.1% (w/v) saponin and 0.2% BSA (w/v) for another 30
min at 25˚C, and washed twice. Finally, the samples were incubated with propidium iodide
(Sigma) for DNA stain at a concentration of 2 mg/ml in PBS for 5 min. After washing with dis-
tillated water, coverslips were mounted on microscope slides and analyzed by fluorescence
microscopy using a DMLB microscope coupled to a DC100 camera (Leica Microscopy Sys-
tems Ltd., Heerbrugg, Switzerland).
In order to evaluate if NETs can immobilize B. parapertussis, 2x105 neutrophils were seeded
in 24 well-plates containing 12 mm coverslip and then stimulated with PMA 100 nM for 1 h to
induce NETs release. Neutrophils were incubated with bacteria for 3 h, washed and fixed with
4% (w/v) paraformaldehyde. NE and DNA were stained as above described. After washing
with distillated water, coverslips were mounted on microscope slides and analyzed by confocal
laser scanning microscope (model TCS SP5; Leica).
NETosis quantification
Quantification of neutrophils that underwent NETosis was performed using the image pro-
cessing software, ImageJ (National Institutes of Health, Bethesda, Maryland, USA, http://
imagej.nih.gov/ij/), as previously described [39] with minor modifications. Briefly, fluores-
cence microscopy images captured with a 40X objective were used to measure individual
nuclear area of neutrophils stained with propidium iodide by adjusting a threshold above back-
ground. The average value of nuclear area of resting neutrophils was chosen as a cutoff value.
Cell nucleus with areas larger than this cutoff value were considered NETting cells. This corre-
lation was confirmed by checking whether randomly chosen cells which nuclear area exceed-
ing the cutoff value showed chromatin colocalizing with the major NETs-associated granular
protein NE. Results were obtained from three independent experiments run in duplicate using
neutrophils from three different donors. At least 500 cells from each condition were examined.
Conditioned medium
CM was obtained as follows. Bacteria were grown in SS medium, washed, and further incu-
bated in DMEM plus 10% FCS at a concentration of 2×108 bacteria/ml for 2 h at 37˚C. Next,
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the medium was filtered with a 0.22 μm membrane filter to remove the bacteria and further
used in experiments. In selected experiments CM was treated with a monoclonal antibody
against both activities of CyaA (2A12), a monoclonal antibody that prevents translocation of
the enzyme catalytic domain into the cell (5D1), or a monoclonal antibody against the hemo-
lytic activity (6E1) of the CyaA [40], all kindly supplied by Erik L. Hewlett, Division of Infec-
tious Diseases and International Health, Department of Medicine, University of Virginia,
Charlottesville, Virginia, USA. In other experiments CM was treated with proteinase K (PK)
100 μg/mL for 60 min at 37˚C before used.
DNA degradation studies
DNase activity of B. parapertussis was determined as previously described [41], with minor
modifications. Briefly, purified neutrophil DNA (300 ng) was incubated at 37˚C for 60 min
with PBS (negative control), 500 mU/ml of Micrococcal nuclease I (MNase I) (Roche Diagnos-
tics; Mannheim, Germany) (positive control), B. parapertussis (6x109 colony forming units
(CFU)/ml), or bacterial-free culture supernatant (obtained by filtration of a 20 h bacterial cul-
ture in SS medium). Next, samples were mixed with sample buffer and loaded onto a 1% aga-
rose gel and run in TBE buffer with 1% ethidium bromide at 100 volts.
Bacterial killing by NETs
The ability of NETs to kill B. parapertussis was evaluated as previously described [42] with minor
modifications. Briefly, 2×105 neutrophils were seeded in 24 well-plates and then incubated with
100 nM PMA for 1 h at 37˚C, to induce NETs. Next, neutrophils were treated or not with
100 μg/ml Cytochalasin D (CytD) (Sigma) to inhibit phagocytosis or with 500 mU/ml MNase I,
to breakdown NETs, for 30 min. In control experiments a combination of CytD and MNase I
was used. Neutrophil were then incubated with bacteria (MOI:100) for 3 h and further treated
with MNase I for 20 min to release the bacteria eventually immobilized by NETs. Neutrophils
were further subjected to hypotonic lysis by using 0.1% saponin in sterile deionized water and
serial dilutions of lysates were rapidly plated onto bBGA to enumerate the CFU. To confirm that
NETs can kill B. parapertussis a microscopic analysis using a LIVE/DEAD Cell Viability Assays
Kit (Molecular Probes) was performed according to the manufacturer’s instructions.
Statistical analysis
Student’s t test (95% confidence level) or analysis of variance (ANOVA) was used for statistical
data evaluation. The significance of the differences between the mean values of the data evalu-
ated by ANOVA was determined with the least-significant-difference (LSD) test at a 95% con-
fidence level. Results are shown as means and standard deviations (SD).
Results
B. parapertussis inhibits neutrophil degranulation
We previously demonstrated that in the absence of opsonic antibodies, B. parapertussis avoids
neutrophil intracellular killing by inhibiting phagolysosomal fusion through an O antigen
dependent mechanism [7]. In this study, we investigated whether these interactions modulate
neutrophil degranulation. To this end, human neutrophils were incubated with non-opsonized
B. parapertussis, non-opsonized O antigen deficient B. parapertussis or IgG-opsonized B. para-
pertussis at a MOI of 300. Ten minutes after exposure the azurophil granule enzymeβ-glucu-
ronidase activity in the cell-free supernatants was measured. Supernatant of uninfected
neutrophils was used as negative control. Total β-glucuronidase activity of uninfected
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neutrophils was determined and set as 100%. As can be seen in Fig 1, non-opsonized B. para-
pertussis failed to trigger significant neutrophil degranulation. In contrast, the B. parapertussis
mutant lacking the expression of the O antigen induced strong neutrophil degranulation, sug-
gesting that O antigen blocks degranulation. The ability of B. parapertussis to impair phago-
some-lysosome maturation was previously found abrogated by IgG opsonization of the
bacteria [7]. Accordingly, Fig 1 (S1 Data) shows that IgG-opsonized B. parapertussis also
induced neutrophil degranulation.
We previously found that the interaction of B. parapertussis with lipid rafts through the O
antigen was involved in inhibition of phagosome-lysosome fusion [7]. We examined this inter-
action in relation to neutrophil degranulation by confocal microscopy using flotillin-1 as lipid
raft marker and Lysotracker and LAMP-1 as markers of azurophil [43] and specific granules
[44], respectively. Fig 2 (S2 Data) shows that as early as 10 min post infection, a high number
of wild type bacteria were mainly colocalizing with flotillin-1, and only a small percentage of
bacteria were found colocalizing with LAMP-1 or Lysotracker. On the other hand, at the same
time point post infection, neither the O antigen deficient mutant nor the IgG-opsonized bacte-
ria were found colocalizing with flotillin-1, whereas they did colocalize with the LAMP-1 or
Lysotracker markers (Fig 2). In control experiments we further confirmed that, as previously
found [7], the treatment of neutrophils with β-methyl cyclodextrin, a compound that disrupts
cholesterol-rich domains by extracting cholesterol, did not affect the attachment of the O anti-
gen deficient mutant but did induce a significant decrease in the number of attached wild type
B. parapertussis. Neutrophils treatment with β-methyl cyclodextrin, on the other hand, did not
affect the colocalization of LAMP-1 positive compartments with the O antigen deficient
mutant strain. Neither was affected the level of colocalization of the wild type strain of B.
Fig 1. Non-opsonized B parapertussis fails to trigger neutrophil degranulation. Neutrophils were
incubated with non-opsonized B. parapertussis (Bpp), non-opsonized B. parapertussis Δwbm (BppΔwbm), or
IgG-opsonized B. parapertussis (IgG-Bpp) at a MOI of 300. The release of β-glucuronidase 10 min post
infection was expressed as a percentage of the total β-glucuronidase cell content. The data represent the
means ± SD of three independent experiments. The β-glucuronidase activity in the cell free supernatant of
neutrophils infected with non-opsonized B. parapertussis was significantly different from the β-glucuronidase
activity in the cell free supernatant of neutrophils infected with opsonized B. parapertussis or the O antigen
deficient B. parapertussis (*P <0.05).
doi:10.1371/journal.pone.0169936.g001
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parapertussis with LAMP-1 positive compartments in β-methyl cyclodextrin treated neutro-
phils, which is in agreement with the finding that the few bacteria found in these neutrophils
were colocalizing with the residual flotillin-1 positive spots (Fig 2C). Accordingly, β-glucuroni-
dase release was not modified by treatment of neutrophils with β-methyl cyclodextrin prior to
incubation with either the wild type strain or the O antigen deficient mutant (data not show).
All together, these results suggest that B. parapertussis inhibits neutrophil degranulation via an
O antigen- lipid raft- dependent mechanism.
B. parapertussis does not induce NETs in resting neutrophils
We next investigated whether the interaction of B. parapertussis with neutrophils induces
NETosis, the other neutrophil extracellular bactericidal mechanisms. NETs induction was
evaluated by fluorescence microscopy using a DNA intercalating dye and specific antibodies
against NET-associated proteins. Fig 3 (S3 Data) shows that neutrophils that were incubated
with medium alone did not undergo NETosis and exhibit a lobulated nucleus, NE is not colo-
calizing with the cell DNA, and no extracellular DNA structures can be observed. In contrast,
neutrophils that underwent NETosis by PMA treatment or exposure to P. aeruginosa at an
MOI of 10 showed a decondensed nucleus in which the chromatin colocalizes with NE and
extracellular structures in which chromatin and NE are colocalizing, respectively. In contrast,
B. parapertussis failed to induce NETosis at any MOI assayed, indicating that B. parapertussis
does not induce NETosis in resting neutrophils.
To evaluate whether the inhibitory effect of B. parapertussis on NETs formation was depen-
dent on any of the Bvg-regulated virulence factors or bacterial viability, neutrophils were incu-
bated with avirulent B. parapertussis or inactivated bacteria, respectively. As can been seen in
Fig 4 (S4 Data), neither avirulent nor inactivated B. parapertussis induced NETosis. These
results show that the lack of induction of NETs release in resting neutrophils by B. parapertus-
sis is not dependent on a Bvg-regulated virulence factor or bacterial viability.
Since the O antigen has been found responsible for preclusion of neutrophil activation dur-
ing the interaction with B. parapertussis [7], we investigated the relationship between the lack
of NETs induction in resting neutrophils infected with B. parapertussis and the expression of
the O antigen. As can been seen in Fig 4, neutrophils that were infected with an O antigen defi-
cient mutant strain did not induce NETs formation, indicating that the O antigen is not
involved in the preclusion of NET release.
The absence of NETosis upon neutrophil infection with the wild type B. parapertussis is in
agreement with the lack of oxidative burst response observed in previous studies [7] and con-
firmed here for the whole period of time of the experiment (Fig 5). Since incubation of neutro-
phils with PMA is known to induce NETs formation in a ROS-dependent way [26], PMA-
treated neutrophils were used as positive control. The ROS production was evaluated during 4
h after infection. Fig 5 (S5 Data) shows that PMA treatment induced an effective ROS produc-
tion in neutrophils while B. parapertussis or medium alone did not. The O antigen defective
mutant of B. parapertussis, however, induced a low but significant level of oxidative burst
response (Fig 5, S5 Data) but did not promote NETs release. These results might indicate that
ROS induction or, at least, this level of ROS, is not sufficient to induce NETosis.
B. parapertussis inhibits NETs release in PMA stimulated neutrophils
NETosis is induced in vivo by a wide range of stimuli that includes different cytokines, bacte-
rial components or a combination of these and other signals [21]. To examine whether B. para-
pertussis is able to actively inhibit NETs formation neutrophils infected with B. parapertussis
(MOI: 10) for 30 min were treated with PMA and 4 h later NETs formation was evaluated by
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Fig 2. B. parapertussis entry through lipid rafts prevents fusion of nascent phagosomes with specific
and azhurophil granules. Neutrophils were incubated with non-opsonized B. parapertussis (Bpp), non-
opsonized B. parapertussis Δwbm (BppΔwbm), or IgG-opsonized B. parapertussis (IgG-Bpp) at a MOI of 300
for 10 min at 37˚C. After washing, samples were incubated with or without Lysotracker (azhurophil granule
marker), fixed and permeabilized prior to incubation with antibodies against B. parapertussis to FITC stained
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fluorescence microscopy. Neutrophils treated with or without DPI for 30 min before PMA
treatment were used as a control of PMA-induced NETs inhibition and positive control,
respectively. Fig 6 (S6 Data) shows that B. parapertussis efficiently inhibits PMA-induced
NETs. In order to determine whether this inhibition depends on bacterial virulence factors or
bacterial viability we investigated the effect of avirulent B. parapertussis or inactivated bacteria
on PMA induction of NETs. As can be seen in Fig 6 (S6 Data), PMA treatment induced NETo-
sis in neutrophils previously incubated with either inactivated or avirulent B. parapertussis,
suggesting that the active form of a Bvg-regulated factor is involved in the observed inhibition.
To further elucidate whether the inhibitory factor was released into the surrounding medium,
a CM was prepared by incubating virulent bacteria (Bvg+ CM) or avirulent bacteria (BvgCM)
in the medium for 2 h. Each CM was then filtered to remove the bacteria and further used to
treat the neutrophils 30 min before PMA addition. Fig 7 shows that treatment of neutrophils
with Bvg+ CM prior to PMA stimulation inhibited PMA induction of NETs. On the other
hand, incubation of neutrophils with the BvgCM did not inhibit PMA-induced NETs release
(Fig 7, S7 Data). Finally, both Bvg+ CM and BvgCM were treated with proteinase K prior to
incubation with neutrophils and further treated with PMA. Proteinase K treatment abolished
the capacity of the Bvg+ CM to inhibit NETs formation in response to PMA, but had no effect
on Bvg¯ CM (Fig 7, S7 Data), indicating that the factor blocking NET formation is a protein
sensitive to proteinase K.
Having in mind that PMA induces NOX/ROS-dependent NETs formation [26], we next
evaluated whether Bvg+ CM inhibits ROS production in PMA treated neutrophils. To this
end, neutrophils were treated with either Bvg+ CM or Bvg- CM for 30 min prior to PMA addi-
tion. Generation of ROS was measured for at least 2 h post treatment. Neutrophils stimulated
with PMA were used as a positive control for ROS production. Neutrophils incubated with the
NOX inhibitor DPI prior to PMA addition were used as a control for inhibition of PMA-
induced ROS. The results presented in Fig 8 (S8 Data) showed that Bvg+ CM inhibited PMA
induced ROS in neutrophil, whereas the Bvg- CM did not. Again, proteinase K treatment of
Bvg+ CM abrogated the inhibition of PMA-induced ROS. Altogether these results suggest that
Bvg-regulated proteins released into the extracellular medium prevent PMA induction of
NETs release by NOX/ROS inhibition.
B. parapertussis CyaA inhibits ROS-dependent NETs generation
Previous studies have shown that B. pertussis CyaA inhibits PMA-generated NETs by ROS
inhibition [45]. B. parapertussis also expresses CyaA in a Bvg-regulated manner. This protein
the bacteria. Samples that were not incubated with LysoTracker were fixed and permeabilized prior to
incubation with antibodies against either flotillin-1 (red) (lipid raft marker) or LAMP-1 (red) (specific granule
marker). B. parapertussis was FITC stained by using antibodies against bacteria. Finally samples were
analyzed by confocal microscopy. (A) Colocalization of bacteria with lipid rafts is reflected by green-
fluorescent B. parapertussis surrounded by red labeled flotillin-1. Bacterial interaction with either specific or
azhurophilic granules is reflected by green-fluorescent B. parapertussis surrounded by red labeled LAMP-1 or
Lysotracker positive compartments, respectively. Representative panels of one of three independent
experiments are shown. Scale bar: 5 μm. (B) The bars indicate the respective percentages of bacteria
colocalizing with a given marker. The data represent the means ± SD of three independent experiments. At
least 50 phagosomes were counted per sample. The percentage of colocalization of non-opsonized B.
parapertussis with a given marker was significantly different from the percentage of colocalization with the
respective marker in neutrophils infected with either the non-opsonized B. parapertussis Δwbm or the IgG-
opsonized B. parapertussis (*P <0.05). (C) Neutrophils were treated with a cholesterol-depleting drug (β-
methyl cyclodextrin, 10 mg/ml) prior to incubation with Bpp or BppΔwbm (both at an MOI of 300) for 10 min at
37˚C. After washing, cells was fixed and permeabilized prior to incubation with antibodies against B.
parapertussis to FITC stain the bacteria and antibodies against either flotillin-1 (red) or LAMP-1 (red).
Representative panels of one of three independent experiments are shown. Scale bar: 5 μm.
doi:10.1371/journal.pone.0169936.g002
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toxin is released into the extracellular medium and could be responsible for the observed inhi-
bition of PMA stimulated NETs by Bvg+ CM. To investigate the role of CyaA, the Bvg+ CM
was incubated with a monoclonal antibody against CyaA (2A12), which partially blocks both
the adenylate cyclase and hemolytic activities of this toxin. Neutrophils were incubated with
this 2A12-treated Bvg+ CM 30 min before PMA treatment and NETs formation was
Fig 3. B. parapertussis precludes NETs release in resting neutrophils. Neutrophils were infected with
non-opsonized B. parapertussis (Bpp) (MOI: 10, 50 or 100) or P. aeruginosa (Pa) (MOI: 10) for 4 h at 37˚C.
Samples were fixed and permeabilized prior to labeling the NE in green and neutrophil DNA with a red
fluorescent dye. Neutrophils incubated with PMA or medium alone were used as a positive and negative
control, respectively. Samples were analyzed by fluorescence microscopy and the number of NETting cells
was determined by the ImageJ softaware. At least 500 cells were counted per sample. (A) Representative
microscopy images of neutrophils 4 h post infection are shown. Scale bar: 20 μm. (B) The bars represent the
percentage of neutrophils that underwent NETosis. The data represent the mean ± SD of three experiments
with neutrophils from different donors. ND: non-determinable (NETotic cells are no longer observed; only big
clusters of NETs are seen). The percentage of NETting cells in PMA treated neutrophils was significantly
different from the percentage of NETting cells observed in the other samples (*P <0.05).
doi:10.1371/journal.pone.0169936.g003
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determined by fluorescence microscopy as described above. As can be seen in Fig 9A and 9B,
the 2A12 antibody abrogated the inhibitory effect of the Bvg+ CM on PMA-induced NETs. To
evaluate which of the toxin activities is responsible for this inhibition, Bvg+ CM was incubated
with either a monoclonal antibody against adenylate cyclase activity (5D1), which prevents
translocation of the enzyme catalytic domain into the cell without affecting the binding of the
toxin to cells, or with a monoclonal antibody against the hemolytic activity of this toxin (6E1),
which binds to the hemolytic domain of the enzyme without impairing intracellular toxin-
Fig 4. Preclusion of NETs release by B. parapertussis does not depend on Bvg-regulated factors,
bacterial viability, or O antigen expression. Neutrophils were incubated with formalin inactivated B.
parapertussis (FK Bpp), avirulent B. parapertussis (Bvg- Bpp), or B. parapertussis Δwbm (BppΔwbm) (MOI:
100) for 4 h at 37˚C. Neutrophils incubated with either medium alone or PMA were used as negative and
positive controls, respectively. After incubation, samples were fixed and permeabilized prior to labeling the NE
in green and neutrophil DNA with a red fluorescent dye. Samples were analyzed by fluorescence microscopy
and the number of NETting cells was determined by the ImageJ softaware. At least 500 cells were counted
per sample. (A) Representative microscopy images of each condition are shown. Scale bar: 20 μm. (B) The
bars represent the percentage of neutrophils that underwent NETosis. The data represent the mean ± SD of
three experiments with neutrophils from different donors. The percentage of NETting cells in PMA treated
samples was significantly different from the percentage of NETting cells observed in the other samples (*P
<0.05).
doi:10.1371/journal.pone.0169936.g004
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induced cAMP accumulation. Fig 9A and 9B (S9 Data) shows that 2A12 and 5D1 antibody
abolished PMA-induced NETs inhibitory activity of Bvg+ CM. On the other hand, treatment
with 6E1 had no effect on the inhibitory activity of Bvg+ CM. These results indicate that the
inhibition of PMA-induced NETs by B. parapertussis depends on adenylate cyclase activity of
CyaA. In agreement with these results, incubation with 2A12 or 5D1 suppressed the inhibitory
activity of Bvg+ CM on the PMA-induced ROS (Fig 9C, S10 Data), while incubation with 6E1
had no effect. These results demonstrate that CyaA, through its adenylate cyclase activity, pre-
vents PMA induction of NETs release through NOX/ROS inhibition.
NETs trap and kill B. parapertussis
Although B. parapertussis per se does not seem to induce NETs, NETs can be induced by many
different stimuli in vivo at the site of infection [21]. We investigated whether these extracellular
structures can trap and kill B. parapertussis. To this end, NETs were induced by PMA (100
nM) treatment before adding B. parapertussis. The capacity of NETs to immobilize B. paraper-
tussis was examined by confocal microscopy. As can been seen in Fig 10 (S11 Data), NET
structures stained for DNA (red) and NE (green) are surrounding B. parapertussis bacteria
(red; stained for DNA), indicating that NETs can trap B. parapertussis. Fig 10 shows the num-
ber of bacteria attached to NETs as compared with the number of bacteria taken up by non-
NETting neutrophils at two different multiplicities of infection, 10 and 100. In both cases
NETs captured more than 80% of the total number of bacteria (90.07% ± 11.37 and 85.96% ±
18.46, respectively).
Several pathogens may escape from NETs by breaking these structures by a self-DNase
activity [46–48]. We investigated whether B. parapertussis can breakdown extracellular DNA
by determining bacterial DNase activity both in the whole cell bacteria and in bacterial-free
culture supernatant by incubation with purified neutrophil DNA for 60 min. DNA integrity
was evaluated by agarose gel electrophoresis. As can be seen in the Fig 11 we found neither B.
parapertussis cell-associated nor secreted DNAase activity, suggesting that this bacterium does
not have this mechanism for NETs evasion.
Fig 5. B. parapertussis does not induce ROS in resting neutrophils. B. parapertussis (Bpp) or B.
parapertussis Δwbm (BppΔwbm) were incubated with neutrophils (MOI: 100) and luminol at 37˚C. Neutrophils
incubated with medium alone and luminol served as a negative control. Neutrophils incubated with PMA were
used as positive controls. Chemiluminescence response was measured every 5 min. The data are
representative of three independent experiments. RLU, relative light units.
doi:10.1371/journal.pone.0169936.g005
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Fig 6. B. parapertussis inhibits PMA-induced NETs through a Bvg-regulated factor. Neutrophils were
incubated with virulent B. parapertussis (Bvg+ Bpp), formalin inactivated B. parapertussis (FK Bpp), avirulent
B. parapertussis (Bvg- Bpp) (MOI 10), or DPI for 30 min at 37˚C prior to PMA treatment. Neutrophils incubated
with medium alone were used as negative control. Neutrophils incubated with PMA alone were used as
positive control. Neutrophils treated with DPI 30 min before PMA treatment were used as control of PMA-
induced NETs inhibition. Four hours post infection samples were fixed and permeabilized prior to labeling the
NE in green and neutrophil DNA in red. Samples were analyzed by fluorescence microscopy and the number
of NETting cells was determined by the ImageJ software. At least 500 cells were counted per sample. (A)
Representative microscopy images of each condition are shown. Scale bar: 20 μm. (B) The bars represent
the percentage of neutrophils that underwent NETosis. The data represent the mean ± SD of three
experiments with neutrophils from different donors. * indicates a P value <0.05 for comparison to results for
neutrophils incubated with medium alone.
doi:10.1371/journal.pone.0169936.g006
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Fig 7. A B. parapertussis secreted Bvg-regulated virulence factor is involved in PMA-induced NETs
inhibition. CM was prepared by incubating 2x108 CFU/ml of virulent B. parapertussis (Bvg+ CM) or avirulent
B. parapertussis (Bvg- CM) in medium for 2 h. In some samples CM was treated with proteinase K (PK)
(100 μg/mL) for 60 min at 37˚C prior use. Neutrophils were incubated with each CM 30 min before treatment
with PMA. Neutrophils incubated with PMA alone were used as positive control. Four hours after PMA
treatment samples were fixed and permeabilized prior to labeling the NE in green and neutrophil DNA in red.
Samples were analyzed by fluorescence microscopy and the number of NETting cells was determined by the
ImageJ softaware. At least 500 cells were counted per sample. (A) Representative microscopy images of
each condition are shown. Scale bar: 20 μm. (B) The bars represent the percentage of neutrophils that
underwent NETosis. The data represent the mean ± SD of three experiments with neutrophils from different
donors. The percentage of NETting cells in neutrophils incubated with Bvg+ CM prior to PMA treatment was
significantly different from the percentage of NETting cells observed in the other samples (*P <0.05).
doi:10.1371/journal.pone.0169936.g007
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Since some microorganisms can be trapped but not killed by NETs [20], we investigated B.
parapertussis survival after NETs encounter. Again, NETs were induced by PMA treatment
before infection with B. parapertussis. Bacterial survival was evaluated 3 h after infection. CFU
counts of bacterial inoculum was determined and set as 100%. As can be seen in Fig 12 (S12
Data), PMA-induced NETs significantly reduced the number of viable bacteria. In order to
discriminate between bacteria killed by NETs or phagocytosis, neutrophils were either incu-
bated with CytD or MNase I, prior to incubation with bacteria. CytD treatment inhibits phago-
cytosis, while MNase I treatment breaks down NETs structure. A combination of MNase I and
CytD was also used to exclude both killing effects. Fig 12 show that the reduction in the num-
ber of viable B. parapertussis in PMA treated neutrophils was due to the bactericidal activity of
NETs.
Discussion
Neutrophils are rapidly recruited by microbial infection, and have a variety of anti-bacterial
mechanisms. To survive this onslaught, many microbial pathogens have evolved strategies to
evade or counteract these mechanisms to successfully infect the host. We have previously
found that in the absence of opsonic antibodies B. parapertussis avoids neutrophil intracellular
bactericidal mechanism by multiple mechanisms [7]. According to those results, the great
majority of bacteria remain extracellularly, where they might be subject to neutrophil degranu-
lation and NETs release. In this study we investigated the relevance of these neutrophil extra-
cellular bactericidal mechanisms in the control of B. parapertussis.
Degranulation usually takes place once phagocytosis is initiated and neutrophil cytoplasmic
granules are fused with nascent unclosed phagosomes leading to phagolysosome formation
[11, 12]. This process eventually leads to the release of bactericidal granular components into
Fig 8. A Bvg-regulated virulence factor secreted into extracellular medium is involved in the
preclusion of ROS generation in PMA treated neutrophils. CM prepared by incubating 2x108 CFU/ml of
virulent B. parapertussis (Bvg+ CM) or avirulent B. parapertussis (Bvg- CM) in medium for 2 h were used to
incubate neutrophils 30 min before treatment with PMA. In some cases the CM was treated with proteinase K
(PK) (100 μg/mL) for 60 min at 37˚C, and further used to incubate neutrophils 30 min before treatment with
PMA. Neutrophils incubated with medium alone and luminol served as a negative control. Neutrophils treated
with DPI 30 min before PMA treatment were used as a control of PMA-induced NETs inhibition (DPI).
Neutrophils incubated with PMA alone were used as positive control. Chemiluminescence responses were
measured every 10 min in the presence of luminol. Data are representative of three independent experiments.
RLU, relative light units.
doi:10.1371/journal.pone.0169936.g008
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Fig 9. B. parapertussis adenylate cyclase inhibits NETs and ROS generation in PMA treated
neutrophils. CM prepared by incubating 2x108 CFU/ml of virulent B. parapertussis (Bvg+ CM) in medium for
2 h was used to incubate neutrophils 30 min before treatment with PMA. In some cases CM was treated with
antibodies against both activities of adenylate cyclase toxin (2A12), or antibodies against either adenylate
cyclase (5D1) or the haemolytic (6E1) activity. Four hours post incubation samples were fixed and
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permeabilized prior to labeling the NE in green and neutrophil DNA in red. Neutrophils incubated with DPI 30
min before PMA treatment were used as a control of inhibition of PMA-induced NETs (DPI). Neutrophils
incubated with PMA alone were used as a positive control. The percentage NETing cell was determined using
the ImageJ softaware. (A) Representative microscopy images of each condition are shown. Scale bar: 20 μm.
(B) The bars represent the percentage of neutrophils that underwent NETosis. The data represent the
mean ± SD of three experiments with neutrophils from different donors. * indicates a P value <0.05 for
comparison to results for control of PMA-induced NETs inhibition (DPI). (C) Chemiluminescence responses of
neutrophils incubated with 2A12, 5D1, or 6E1-treated Bvg+ CM prior to the incubation with PMA. Neutrophils
incubated with medium alone and luminol served as a negative control. Neutrophils incubated with PMA alone
were used as positive control. Chemiluminescence was measured every 10 min during the whole time of the
experiment. Data are representative of three independent experiments. RLU, relative light units.
doi:10.1371/journal.pone.0169936.g009
Fig 10. NETs can trap and immobilize B. parapertussis. Neutrophils were incubated with PMA (100 nM)
for 1 h prior to infection with B. parapertussis (MOI 10 or 100) for 4 h at 37˚C. Next, neutrophils were fixed and
permeabilized prior to labeling the NE in green and both the neutrophil and bacterial DNA in red. (A)
Representative confocal microscopy images of three independent experiments are shown. Scale bar: 10 μm.
(B) The number of associated bacteria to both NETs- and non-NETting neutrophils was determined by
analyzing at least 20 fields per sample. The bars represent the number of associated bacteria to either NETs-
or non-NETting neutrophils. The data represent the mean ± SD of at least three experiments with neutrophils
from different donors. The number of associated bacteria to NETs was significantly different to the number of
associated bacteria to non-NETting cells at both MOI assayed (*P <0.05).
doi:10.1371/journal.pone.0169936.g010
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the surrounding medium ultimately killing extracellular bacteria. The results of this study
showed that at a multiplicity of infection as high as 300 bacteria per neutrophil there was not
significant degranulation, as determined by the lack of β-glucuronidase activity in the cell-free
supernatants of infected cells. A mutant lacking O antigen stimulated degranulation, indicat-
ing both that B. parapertussis can stimulate this neutrophil response and that the O antigen
molecule blocks it. We had previously shown that the O antigen targets the bacteria to the lipid
raft domains on the host cell membrane [7]. Bacterial entry through lipid raft platforms is
involved in the evasion of intracellular signaling pathways linked to the activation of
Fig 11. B. parapertussis does not have DNAse activity. Gel electrophoresis analysis of DNA (300 ng)
incubated 1 h a 37˚C with PBS (PBS), B. parapertussis (Bpp), culture supernatant of B. parapertussis
(supernatant), and MNase I (500 mU/ml). Representative images are shown.
doi:10.1371/journal.pone.0169936.g011
Fig 12. B. parapertussis is killed by NETs. Neutrophils were incubated with PMA (100 nM) for 1 h at 37˚C
to induce NETs release. Next, neutrophils were treated with cytochalasinD (100 μg/ml; CytD), MNase I (500
mU/ml), or a combination of both for 30 min at 37˚C. Neutrophils were then incubated with B. parapertussis
(Bpp) (MOI 100) for 3 h at 37˚C. Next, all samples were treated with MNase for 20 min to release entrapped
bacteria from NETs and serial dilutions of cell lysates were rapidly plated onto bBGA to enumerate CFU. The
percentage of viable bacteria was referred to bacterial inoculums. The number of viable B. parapertussis in
samples treated with MNase I prior bacterial infection was significantly different from that found in samples
that were not treated with MNase I. * indicates a P value <0.05 for comparison to results for PMA-treated
neutrophils infected with Bpp.
doi:10.1371/journal.pone.0169936.g012
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neutrophil bactericidal mechanisms [49, 50]. Soon after bacteria-neutrophil contact confocal
studies showed the wild type strain of B. parapertussis in close contact with lipid rafts at the
plasma membrane of neutrophils, and the absence of specific and azurophilic granules in the
bacterial surroundings at the site of entry during phagocytosis. Conversely, the B. parapertussis
O antigen-deficient mutant that did not colocalize with lipid rafts domains was found sur-
rounded by a great number of specific and azurophilic granules. The fusion of these cyto-
plasmic granules with unclosed phagosomes containing B. parapertussis O antigen mutant
probably contributed to the observed robust neutrophil degranulation. This key role of the O
antigen in the inhibition of neutrophils degranulation adds to the already long list of the bacte-
rial protective characteristics of this molecule.
IgG opsonization of B. parapertussis overcomes O antigen-mediated inhibition of degranu-
lation, as determined by the high release of β-glucuronidase in the cell supernatant of neutro-
phils infected with IgG opsonized B. parapertussis. This result is in agreement with the finding
that IgG-opsonized bacteria do not enter through lipid rafts domains, are trafficked to lyso-
somes, and strongly activate neutrophils [7]. These results stress the need for opsonic antibod-
ies at the site of infection not only to promote efficient phagocytosis and intracellular bacterial
inactivation [7] but also to induce extracellular bacterial killing through neutrophil
degranulation.
NETs represent a complementary approach to contain and kill extracellular bacteria. Sev-
eral stimuli can activate specific signaling pathways leading to NETotic cell death and the
release of a mixture of granular content associated with DNA fibers in the extracellular
medium [9]. This is a potent antimicrobial mechanism since the NETs immobilize and eventu-
ally kill microbes that are in the surrounding of the neutrophil. Bacterial components are
strong inductors of NETs [51]. However, we observed that B. parapertussis interactions with
resting neutrophils do not induce NETs production. According to our results B. parapertussis
does not induce NETosis even at high multiplicities of infections at which fungi, virus, proto-
zoa, and several bacterial pathogens induce a strong NETosis [21]. Some pathogens use active
mechanisms to circumvent this neutrophil extracellular killing mechanism, like the secretion
of nucleases that break down NETs [46–48]. But B. parapertussis did not express detectable
cell-associated nor secreted DNase activity. It does expresses a potent set of Bvg-regulated viru-
lence factors that mediates several immune evasion mechanisms, but none of these virulence
factors were found implicated in the lack of NETs induction in resting neutrophils. The lack of
induction of NETs in resting neutrophils by B. parapertussis was not even dependent on the
viability of the bacteria as was proved by infection with inactivated B. parapertussis.
Bacterial LPS is a strong NETs inductor [28, 52]. However, bacterial pathogens have
coevolved with their host to hide themselves from recognition by the immune system. In some
pathogens adaptation to humans has provided selective pressure to modify surface structures
like LPS. Previous studies have shown that B. parapertussis LPS has specific modifications that
determine its low stimulatory activity of the immune system [7, 53, 54]. Particularly, the LPS O
antigen decoration has been found responsible for the prevention of neutrophil oxidative
burst by B. parapertussis [7]. Since ROS production is required by almost all stimuli that lead
to NETs release [25, 26], we hypothesized that the O antigen was involved in the lack of NETs
induction. However, the O antigen deficient B. parapertussis, although able to induce a small
but significant oxidative burst, did not promote NETs release. These results seem to indicate
that either ROS stimulation induced by the O antigen mutant strain is not strong enough to
promote NETs release (like observed for B. pertussis [45]) or other required mechanisms are
not triggered during this bacterial-cell interaction, i.e. autophagy activity [26]. In summary,
the lack of NETs induction by B. parapertussis seems associated to the low stimulatory poten-
tial of its LPS as previously found for other pathogens like Brucella abortus [55].
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Neutrophil activation and NETs release can be initiated by several stimuli such as a combi-
nation of cytokines, or bacterial components (LPS) plus proinflamatory cytokines [21], among
others. In this study, we challenged the ability of B. parapertussis to inhibit NETs release in the
presence of the most potent NETs inducer, PMA [26]. We observed that B. parapertussis is
able to inhibit PMA-induced NETosis by preventing PMA-induced oxidative burst. This inhi-
bition proved dependent on the CyaA released into the extracellular medium indicating that
NETs inhibition does not require the close proximity of bacteria with neutrophils. CyaA has
two different biological activities, a hemolysin activity implicated in cell lysis, and the adenylate
cyclase activity that intoxicates target cell by increasing the intracellular level of cAMP. By
using specific monoclonal antibodies against the different CyaA activities, we found that the
adenylate cyclase activity is responsible for both ROS and NETosis inhibition in PMA-stimu-
lated neutrophils. Our findings are in agreements with those of Eby, et al. who demonstrated
that CyaA inhibits PMA-induced NOX activity [45]. Inhibition of NOX prevents ROS genera-
tion and chromatin decondensation which is essential for NET formation [26]. In this previous
work, Eby, et al. [45] suggested that CyaA inhibits NOX activity through the inhibition of the
Raf-MEK-ERK signaling pathway, which is involved in the assembly and activation of the
NOX. Accordingly, we observed that CyaA arrests PMA treated neutrophils in a delobulated
nuclei stage (Fig 6), which is typical in the inhibition of Raf-MEK-ERK signaling pathway [56].
Therefore, like B. pertussis, B. parapertussis inhibition of PMA-induced NETs probably
depends on an active inhibition of Raf-MEK-ERK signaling pathway mediated by CyaA.
While many human pathogens have been shown to induce NETs formation, and some have
mechanisms to escape from NETs, B. parapertussis is the first reported human pathogen that
does not induce NETs and had the ability to inhibit NET formation. Through two different
mechanisms, one related to the lack of proper NET-inducer stimuli and the other related to a
virulence factor-mediated inhibition, B. parapertussis control an essential neutrophil mecha-
nism against microbial infections. This dual strategy to avoid NETs induction has only been
described in the Gram-positive bacterium Lactobacillus rhamnosus [57], but to our knowledge
there is no precedent in Gram-negative bacterium. Interestingly, unlike other pathogens that
avoid neutrophil extracellular killing by escaping from NETs, the capacity of B. parapertussis
to block NETs induction can prevent an exacerbated inflammatory response originated by the
release of tissue-damaging molecules after neutrophil lysis during NETs release. Furthermore,
NETs inhibition mediated by an excreted virulence factor might be useful for B. parapertussis
at the site of infection where several potential soluble NETs inducer stimulus may be present.
By being able to control NETs release without intimate contact with the cell B. parapertussis
generates a relatively large environment free of NETs. This NETs release control might be
quite relevant for B. parapertussis survival since NETs can efficiently trap and kill this bacte-
rium. On the other hand, the inhibition of neutrophil death mechanisms like NETosis, might
be advantageous for a bacterium like B. parapertussis that is able to remain alive inside the cell
as a transient intracellular stage.
We have previously shown that opsonic antibodies are required for neutrophils and macro-
phages to efficiently phagocytose and kill B. parapertussis [6, 7]. The results obtained in this
study demonstrate that without opsonizing antibodies this pathogen might also avoid extracel-
lular bactericidal mechanisms of neutrophils. These results are consistent with previous studies
performed in a murine model of infection that demonstrated that B. parapertussis clearance
requires both the presence of neutrophils and specific antibodies against this bacterium [58].
The lack of either precludes bacterial clearance.
Adenylate cyclase has been proposed as a pertussis vaccine candidate. In this work, we
showed that antibodies against B. pertussis adenylate cylcase toxin neutralize B. parapertussis
CyaA released into the extracellular medium allowing NETs induction by stimulated
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neutrophils. Therefore, in the absence of proper opsonic antibodies to induce a strong neutro-
phil bactericidal activity, antibodies against this toxin might be valuable for the control of B.
parapertussis.
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